Surface Oncology Inc reports results for the quarter ended in March - Earnings Summary

Surface Oncology

05/05/2021 13:56

* Surface Oncology Inc  SURF.OQ  reported a quarterly adjusted
loss of 37 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 41 cents per share.
* Revenue fell 95.8% to $1.63 million from a year ago​; 
analysts expected $1.00 million.
* Surface Oncology Inc's reported EPS for the quarter was a loss
of 37 cents​.
* The mean earnings estimate of analysts had fallen by
about 275.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Surface Oncology Inc shares had fallen by 9.6% this
quarter and lost 23.7% so far this year.
* The company reported a quarterly loss of $15.56 million.
* Wall Street's median 12-month price target for Surface
Oncology Inc is $16.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 5 at 12:56 p.m. GMT. ​All
figures in US Dollars.​